Actively Recruiting
Phase II-III Study of Preoperative Chemotherapy with Cabazitaxel, Docetaxel, Mitoxantrone, or Satraplatin Followed by Surgery in Men Aged 40 to 75 With High Risk Prostate Cancer
Led by Shanghai Jiao Tong University School of Medicine · Updated on 2026-01-12
300
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Prostate cancer is a disease where harmful cells grow in the prostate gland, affecting mainly men aged 40 to 75 years in this study. Researchers are exploring whether giving chemotherapy before surgery can better control high-risk prostate cancer and prevent it from becoming resistant to hormone therapy, which is harder to treat. This trial is a Phase II-III randomized study to evaluate chemotherapy agents given before surgery compared to surgery alone in men with localized prostate cancer. Participants receive one of four chemotherapy drugsCabazitaxel, Docetaxel, Mitoxantrone, or Satraplatinadministered as a single agent 45 days before surgery. The chemotherapy is given either intravenously or orally once a week for four weeks, with a 17-day break before the radical prostatectomy surgery. Another group undergoes surgery without any prior chemotherapy, allowing comparison of outcomes between the two approaches. During the study, men will be monitored closely with clinical assessments and imaging to evaluate their health and cancer status. Researchers will measure how long participants remain free of disease over five years, as well as overall survival and metastasis-free survival. The study also examines the impact of chemotherapy on tumor tissue and how it might affect cancer progression. Participation lasts at least five years to carefully track these long-term outcomes.
CONDITIONS
Brief Title
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Research Team
Y
Yu Sun, Ph.D
W
Weijun Ma, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here